Article
Defective pgsA contributes to increased membrane fluidity and cell wall thickening in Staphylococcus aureus with high-level daptomycin resistance.
mSphere - 25 Jun 2024
Freeman Christian D, Hansen Tayte, Urbauer Ramona, Wilkinson Brian J, Singh Vineet K, Hines Kelly M
Abstract excerpt
Daptomycin is a membrane-targeting last-resort antimicrobial therapeutic for the treatment of infections caused by methicillin- and/or vancomycin-resistant Staphylococcus aureus. In the rare event of failed daptomycin therapy, the source of resistance is often attributable to mutations directly within the membrane phospholipid biosynthetic pathway of S. aureus or in the regulatory systems that control cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
